Fused tricyclic compounds useful as anticancer agents
US12410187B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2020 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Dec 13, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The specification relates to compounds of Formula (A) and pharmaceutically acceptable salts thereof. The specification also relates to processes and intermediates used for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.